Fig. 2
From: Clinical characteristics, metastasis patterns, and treatment outcomes of HER2-low breast cancer
Five-years metastasis free survival (MFS) since diagnosis for women and men at stages I to III stratified by HER2-status.
Fig. 2 | Scientific Reports
